Overview

Preemptive Analgesia With Celecoxib for Acute Dental Pain Management

Status:
Recruiting
Trial end date:
2024-04-22
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to compare the effect on postoperative pain of a single agent nonsteroidal anti-inflammatory drug (NSAID) [celecoxib plus placebo] to an NSAID combination [celecoxib plus acetaminophen] administered preemptively to patients prior to impacted third molar surgery. .
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston
Treatments:
Acetaminophen
Celecoxib
Criteria
Inclusion Criteria:

- American Society of Anesthesiologists (ASA) physical status classification 1 or 2

- at least 1 impacted mandibular third molar planned for extraction

Exclusion Criteria:

- ASA 3 or higher for physical status classification

- severe pericoronitis associated with third molar to be extracted

- any known allergies to NSAIDs, aspirin, acetaminophen, sulfa drugs

- history of cardiovascular or cerebrovascular disease

- hepatic disease or impairment

- pregnancy